Telehealth platform Hims & Hers Health has appointed Dr. Anant Vinjamoori as its Chief Medical Officer, focusing on expanding preventive care and longevity offerings for men.
Hims & Hers Health, a prominent telehealth platform, has announced the appointment of Dr. Anant Vinjamoori as the new Chief Medical Officer (CMO) for its men’s brand, Hims. This strategic move is part of the company’s initiative to enhance its offerings in preventive healthcare and longevity medicine.
In his new role, Dr. Vinjamoori will provide clinical guidance to shape the future of the Hims brand, which encompasses key areas such as sexual health, hormone health, dermatology, weight loss, and mental health. He will also oversee the development of emerging categories, including longevity medicine and peptide therapy. Dr. Vinjamoori will report directly to Dr. Pat Carroll, the Global Chief Medical Officer of Hims & Hers.
Dr. Vinjamoori brings a robust academic background, having earned his MD from Harvard Medical School while simultaneously completing an MBA at Harvard Business School. With over a decade of clinical and executive experience in primary care, internal medicine, and longevity, he has previously held leadership positions at notable health technology companies, including Virta Health and Modern Age.
His expertise lies in integrating clinical practices with advanced diagnostics and targeted therapies, such as peptides, aimed at optimizing sleep, body composition, cognition, and physical recovery. Additionally, Dr. Vinjamoori is the founder of Next Generation Medicine, an initiative dedicated to providing medical education and artificial intelligence tools to help clinicians implement evidence-based longevity care protocols safely and effectively.
Beyond his role at Hims, Dr. Vinjamoori has served as an advisor to various consumer wellness brands, including Midi Health and Superpower, and has authored several peer-reviewed clinical publications. The corporate medical leadership team at Hims & Hers boasts over 100 years of combined clinical experience, and company officials believe that Dr. Vinjamoori’s background will ensure that the platform’s expanding wellness treatments remain grounded in current research and adhere to strict clinical guidelines.
Dr. Vinjamoori has observed a shift in consumer behavior, noting that modern patients are increasingly moving away from reactive medical treatments. He emphasized that men are becoming more attentive to science-driven, proactive care to maintain their well-being at every life stage. He believes that Hims possesses the scale and consumer trust necessary to effectively deliver these advanced care innovations.
As Hims & Hers continues to grow, Dr. Vinjamoori’s leadership is expected to play a crucial role in the company’s mission to provide comprehensive and innovative healthcare solutions tailored to men’s needs.
According to The American Bazaar, this appointment marks a significant step for Hims as it seeks to redefine the landscape of men’s health through a focus on preventive care and longevity.